• week of june 10: Greg Kunst - Aurion Biotech

  • Jun 9 2024
  • Length: Less than 1 minute
  • Podcast

week of june 10: Greg Kunst - Aurion Biotech  By  cover art

week of june 10: Greg Kunst - Aurion Biotech

  • Summary

  • Top Stories

    1. Microsoft CEO leaves Starbucks board

    ⁠Geekwire article⁠

    2. Seattle startup wins lawsuit against Boeing

    ⁠Seattle Times article⁠

    3. VC backed biotech Vilya raises $71M

    ⁠Geekwire article⁠

    4. Lightrail SLU location debate

    Opinion 1: ⁠The Stranger article⁠

    Opinion 2: ⁠PSBJ article⁠

    5. New record store on Vashon

    ⁠Seattle Times article⁠

    About guest co-host Greg Kunst - Founder & CEO, Aurion Biotech:

    Greg Kunst founded Aurion Biotech which is a company that develops cell therapies for the treatment of serious eye disorders. He is on the board of Pr3vent, Inc tackling vision health for babies. He's strategic advisor for Oculogica. Prior to this, he held leadership positions at Glockos Corporation and Alcon, both companies tackling eye health.

    Host Rachel Horgan:

    Rachel is an independent event producer, emcee and entrepreneur. She worked for the Business Journal for 5 years as their Director of Events interviewing business leaders on stage before launching the weekly podcast. She earned her communication degree from the University of San Diego.

    Contact:

    Email: ⁠⁠⁠⁠info@theweeklyseattle.com⁠⁠

    Instagram: @theweeklyseattle

    Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.theweeklyseattle.com

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about week of june 10: Greg Kunst - Aurion Biotech

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.